Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04JYW
|
||||
Former ID |
DNC013316
|
||||
Drug Name |
(+/-)-oxiran-2-ylmethyl (9Z)-hexadec-9-enoate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529008] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H34O3
|
||||
Canonical SMILES |
CCCCCCC=CCCCCCCCC(=O)OCC1CO1
|
||||
InChI |
1S/C19H34O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(20)22-17-18-16-21-18/h7-8,18H,2-6,9-17H2,1H3/b8-7-
|
||||
InChIKey |
FWEHVPCBXKCYHE-FPLPWBNLSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529008] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.